tiprankstipranks
Advertisement
Advertisement

Teva says has greater than $10B of innovative pipeline potential

Says well-positioned for margin expansion to 30% OPM in ’27; Geopolitical: Operations remain uninterrupted with no material impact; Emalex transaction and the potential share buyback program aligned with capital allocation strategy.

Claim 55% Off TipRanks

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1